Netherlands· NL-eb9d8b74b915
Ruta graveolens
A medicinal product containing ruta graveolens, registered in Netherlands by Boiron.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- RUTA GRAVEOLENS
- Manufacturer
- Boiron
- Country
- Netherlands (NL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id92623
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ruta graveolens in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fd55c515-85bd-4fb8-8aba-2bd815e3fbf1 GET /v1/drugs/fd55c515-85bd-4fb8-8aba-2bd815e3fbf1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": null,
"route": "Oraal gebruik",
"soort": "RVH",
"source": "cbg_meb",
"smpc_url": null,
"strength": "4 DH t/m 60 DH#2 CH t/m 200 CH#6 K t/m 100.000 K#1 LM t/m 30 LM",
"atc_label": null,
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg92623",
"excipients": null,
"substances": [
"RUTA GRAVEOLENS"
],
"leaflet_url": null,
"authorised_at": "2000/05/08",
"procedure_number": null,
"dispensing_status": "Uitsluitend apotheek of drogist",
"registration_number": "92623",
"additional_monitoring": "N"
}See everything about ruta graveolens.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.